Amy Peterson

Track

Insider profile

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Medical Officer, Immuno-Oncology BeOne Medicines AG None -
Amy Peterson's trades of Exelixis Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Exelixis Inc (EXEL)
Transaction date
Proposed sale
Price
204.14
Quantity 69,524
Value US$3,530,572
US Exelixis Inc (EXEL)
Transaction date
Sale
Price
260.76
Quantity 13,115 -16.5%
Value US$3,022,251
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-16 2025-05-16
US Exelixis Inc (EXEL)
PrS Proposed sale
69,524
204.14
US$3,530,572 		69,524 204.14 US$3,530,572
2025-05-16 2025-05-16
US Exelixis Inc (EXEL)
S Sale
13,115 -16.5%
260.76
US$3,022,251 		13,115 -16.5% 260.76 US$3,022,251
2023-03-20 2023-03-16
S Sale
65,208 +48.9%
246.69
US$3,548,901 		65,208 +48.9% 246.69 US$3,548,901
2022-07-21 2022-07-20
S Sale
7,463 -10.6%
1.42
US$10,612 		7,463 -10.6% 1.42 US$10,612